NVCT (Nuvectis Pharma) Long-Term Debt: $0.00 Mil (As of Mar. 2026)


NVCT Nuvectis Pharma Inc NVCT
30 GF Score
Price $19.48
! 1 Warning Sign
View Full Analysis

What is Nuvectis Pharma Long-Term Debt?

Nuvectis Pharma NVCT -0.87% 30 Long-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus rates NVCT with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Nuvectis Pharma's Long-Term Debt for the quarter that ended in Mar. 2026 was $0.00 Mil.

Nuvectis Pharma  (NAS:NVCT) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Nuvectis Pharma Long-Term Debt Related Terms

Nuvectis Pharma Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Nuvectis Pharma's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvectis Pharma Long-Term Debt Chart

Nuvectis Pharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nuvectis Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NVCT
30GF Score
Nuvectis Pharma Inc NVCT
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Nuvectis Pharma (NVCT) has a Long-Term Debt of $0.00 Mil as of Mar. 2026.
Is Nuvectis Pharma's Long-Term Debt too high?
Nuvectis Pharma's current Long-Term Debt is $0.00 Mil. Overall, Nuvectis Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Nuvectis Pharma's Long-Term Debt compare to AURA and OCS?
Nuvectis Pharma's Long-Term Debt of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Nuvectis Pharma's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nuvectis Pharma stock overvalued right now?
Nuvectis Pharma (NVCT) has a current Long-Term Debt of $0.00 Mil. The current Long-Term Debt is $0.00 Mil. Nuvectis Pharma's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Nuvectis Pharma (NVCT), the current Long-Term Debt is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nuvectis Pharma Business Description

Address 1 Bridge Plaza, 2nd Floor, Suite 275, Fort Lee, NJ, USA, 07024
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
30GF Score

Get the complete analysis for NVCT

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.48
Price